Association among anti-citrullinated protein antibody status, erosive disease and healthcare resource utilization in patients with rheumatoid arthritis

Leslie R. HarroldCorrona, LLC, Waltham, MA, USA; Correspondence[email protected]

Ying ShanCorrona, LLC, Waltham, MA, USA;

Sean E. ConnollyBristol-Myers Squibb, Princeton, NJ, USA;

Evo AlemaoBristol-Myers Squibb, Princeton, NJ, USA;

Sabrina RebelloCorrona, LLC, Waltham, MA, USA;

Lin GuoCorrona, LLC, Waltham, MA, USA;

Joel M. KremerAlbany Medical College and The Center for Rheumatology, Albany, NY, USA

show all

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (5)

Claire E.H. Barber, Diane Lacaille, Ruth Croxford, Cheryl Barnabe, Deborah A. Marshall, Michal Abrahamowicz, Hui Xie, J. Antonio Aviña-Zubieta, John M. Esdaile, Glen S. Hazlewood, Peter Faris, Steven Katz, Paul MacMullan, Dianne Mosher & Jessica Widdifield. (2023) Investigating Associations Between Access to Rheumatology Care, Treatment, Continuous Care, and Healthcare Utilization and Costs Among Older Individuals With Rheumatoid Arthritis. The Journal of Rheumatology 50:5, pages 617-624.
Crossref

Mehran Pournazari, Parisa Feizollahi, Seyed Askar Roghani, Shirin Assar, Parviz Soufivand, Bijan Soleymani, Fariborz Bahrehmand, Zahra Mohammadi Kish & Mahdi Taghadosi. (2021) Increased plasma levels of CCL20 in peripheral blood of rheumatoid arthritis patients and its association with clinical and laboratory parameters. Clinical Rheumatology 41:1, pages 265-270.
Crossref

Xue Han, Francis Lobo, Michael S Broder, Eunice Chang, Sarah N Gibbs, David J Ridley & Irina Yermilov. (2021) Persistence with Early-Line Abatacept versus Tumor Necrosis Factor-Inhibitors for Rheumatoid Arthritis Complicated by Poor Prognostic Factors. Journal of Health Economics and Outcomes Research, pages 71-78.
Crossref

Xue HanFrancis LoboMichael Broder, Eunice Chang, Sarah N. Gibbs, David J. Ridley & Irina Yermilov. (2021) Persistence with Early-Line Abatacept versus Tumor Necrosis Factor-Inhibitors for Rheumatoid Arthritis Complicated by Poor Prognostic Factors. Journal of Health Economics and Outcomes Research 8:1, pages 71-78.
Crossref

York Kiat Tan, HuiHua Li, John Carson AllenJrJr & Julian Thumboo. (2020) Anti‐cyclic citrullinated peptide but not rheumatoid factor is associated with ultrasound‐detected bone erosion among rheumatoid arthritis patients with at least moderate disease activity. International Journal of Rheumatic Diseases 23:10, pages 1337-1343.
Crossref

Association among anti-citrullinated protein antibody status, erosive disease and healthcare resource utilization in patients with rheumatoid arthritis

Articles from other publishers (5)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Association among anti-citrullinated protein antibody status, erosive disease and healthcare resource utilization in patients with rheumatoid arthritis

Citations (5)

Articles from other publishers (5)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date